Search - tctmd.com

Displaying 841 - 860 of 1874

Sort: Relevancy | Date

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

News Industry News

Medtronic Launches SEEQ(TM) Wearable Cardiac Monitoring System in United States

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

News Industry News

CardioMEMS Data Shows Pulmonary Artery Pressure Monitoring Significantly Reduces Heart Failure Hospitalizations in Patients with Chronic Kidney Disease

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Industry News

NATEC Medical Ltd and US Endovascular Collaborate to Deliver a Brand New PTA Generation to the Peripheral US Market

September 15, 2014

Presentation TCT 2014

Middle Peak Medical: Restoration of Coaptation

Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Jason H. Rogers

September 14, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

Practice Patterns of Female Interventionalists Show High Volume of Complex Cases

September 14, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

News Conference News TCT 2014

PCI for CTO Ups Survival vs. Medical Therapy, CABG

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

News Conference News TCT 2014

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

September 14, 2014

Advertisement

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

Medtronic Launches SEEQ(TM) Wearable Cardiac Monitoring System in United States

COMBO Stent Achieves Neointimal Regression at 24 Months

CardioMEMS Data Shows Pulmonary Artery Pressure Monitoring Significantly Reduces Heart Failure Hospitalizations in Patients with Chronic Kidney Disease

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

NATEC Medical Ltd and US Endovascular Collaborate to Deliver a Brand New PTA Generation to the Peripheral US Market

Middle Peak Medical: Restoration of Coaptation

TCT Course Director Outlines Current TAVR Controversies

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Practice Patterns of Female Interventionalists Show High Volume of Complex Cases

PFO Closure for Stroke: A Call to Revise the Guidelines

PCI for CTO Ups Survival vs. Medical Therapy, CABG

Lively Debate on Use of TAVR for Lower-Risk Patients

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

ABSORB EXTEND: BVS Safe Out to 3 Years

Pooled Trial Data Show No Stent Thrombosis Reduction with Biodegradable Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content